ACURX PHARMACEUTICALS ANNOUNCES FIRST PATIENT ENROLLED IN PATHFINDER CLINICAL TRIAL OF IBEZAPOLSTAT IN MULTIPLY-RECURRENT C. DIFFICILE INFECTION

Reuters · 3d ago

Please log in to view news